U.S., July 1 -- ClinicalTrials.gov registry received information related to the study (NCT07675590) titled 'A Study to Evaluate Safety, Tolerability and Pharmacokinetics of Orally Administered TIX100 in Healthy Subjects' on June 18.
Brief Summary: Randomized, Placebo-controlled Study to determine the safety and tolerability of multiple oral doses of TIX100 administered daily for 28 days to otherwise healthy overweight/obese subjects.
Study Start Date: June 22
Study Type: INTERVENTIONAL
Condition:
Health Adult Subjects
Obesity & Overweight
Intervention:
DRUG: TIX100
oral administration over 28 days
DRUG: Placebo
oral administration over 28 days
Recruitment Status: RECRUITING
Sponsor: TIXiMED, Inc.
Disclaimer: Curated by HT Syndi...